Cargando...
Benefit and danger from immunotherapy in myasthenia gravis
In the last years, significant advances have improved the knowledge of myasthenia gravis (MG) immunopathogenesis and have enabled to realize new molecules with a selective action targeting compounds of the immunological system. This review discusses emerging treatments for MG, including complement i...
Guardado en:
| Publicado en: | Neurol Sci |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7861968/ https://ncbi.nlm.nih.gov/pubmed/33543421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10072-021-05077-6 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|